Skip to content
MedsAcross

Brand family

Truvada

United States
Presentations
4
Markets
1

Truvada is a brand of Emtricitabine and Tenofovir disoproxil marketed by Gilead Sciences, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Emtricitabine and Tenofovir disoproxil
Brand owner
Gilead Sciences
Registered in
United States
Strengths and forms
100 mg/150 mg tablet, 133 mg/200 mg tablet, 167 mg/250 mg tablet, 200 mg/300 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Truvada 100 mg/150 mg tabletOralGilead SciencesUS FDAAvailable on request
Truvada 133 mg/200 mg tabletOralGilead SciencesUS FDAAvailable on request
Truvada 167 mg/250 mg tabletOralGilead SciencesUS FDAAvailable on request
Truvada 200 mg/300 mg tabletOralGilead SciencesUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Truvada

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.